QDEL (QuidelOrtho Corp) Market Value to Book Value Ratio

QuidelOrtho Corporation (QDEL) - corporate logo

QuidelOrtho (QDEL) leads the development of rapid tests, allocating colossal funds toward the creation of mobile analyzers. The business aims to capture the express diagnostics niche by integrating home and laboratory systems, with the metric standing at 0.53. The asset value on GURU.Markets, as reflected in this chart, demonstrates the dynamics of a company whose equipment production capacities are operating at maximum efficiency.

QDEL - QuidelOrtho Inc. Market-to-Book Ratio over the range 07/04/2022 - 10/27/2026
Flagship merchandise of QuidelOrtho Corp

Professional selection of resilient assets is based on analyzing the market value premium over net assets, which prevents overpaying for a security at the cycle peak. By studying the changes in the market cap to book capitalization ratio, an investor assesses market expectations regarding the future earnings of QuidelOrtho (QDEL), which are supported by a stable cash flow from regular sales of consumables for diagnostic systems.

Direct competitors

Agilent Technologies (A) - Market Value to Book Value Ratio|DGX (questdiagnostics.com) - Market Value to Book Value Ratio|Market Value to Book Value Ratio ILMN|Market Cap to Net Assets Ratio Exact Sciences Corp|PerkinElmer - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bio-Rad Corp (BIO)|NNNN - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio soterahealth.com SHC|OPKO Health - Market Capitalization to Book Value Ratio|CDNA: Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Maravai LifeSciences Corp|Fulgent (FLGT) - Capitalization to Book Value Ratio|LAB (Standard BioTools Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio CTKB|Market Value to Book Value Ratio OraSure (OSUR)|Market Value to Book Value Ratio exagen.com XGN|MDXH: Market Cap to Net Assets Ratio|Lucid Diagnostics, Inc - Market-to-Book Ratio|Market Value to Book Value Ratio PRE (Prenetics Global Ltd)|IMDX - Market Capitalization to Book Value|trinitybiotech.com - Market Capitalization to Book Value Ratio|PRPH (ProPhase Labs Inc) - Market Capitalization to Book Value|AIMD: Market Value to Book Value Ratio|Market Capitalization to Book Value CODX|HSCS: Market Value to Book Value Ratio|Market Value to Equity Ratio biomerica.com BMRA|Market Cap to Net Assets Ratio CDIO (Cardio Diagnostics Holdings)|Market Capitalization to Book Value Ratio Virax Biolabs Group Limited VRAX|Market Capitalization to Book Value Ratio BJDX (Bluejay)|AWH - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio Accelerate Diagnostics|CENTOGENE (CNTG) - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ENZ (Enzo Biochem Inc.)|Market-to-Book Ratio FRES|Market Value to Book Value Ratio Genetic Technologies (GENE)|Market Value to Book Value Ratio ME (23andMe Inc)|PMD: Market Value to Book Value Ratio